National Institutes of Health Clinical Center (CC)
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, National Institutes of Health Clinical Center (CC) sits in the top decile of US sponsors by registered trial count (#107 of 15,742 sponsors by registered trial count).
National Institutes of Health Clinical Center (CC): 338 sponsored US clinical trials, 22 recruiting.
National Institutes of Health Clinical Center (CC) sponsors 338 registered US clinical trials on ClinicalTrials.gov, 22 of them currently recruiting, and 272 completed. 17 of these trials are in Phase 3-4 (later-stage) and 121 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 8 trials.
Top-decile sponsor footprint
National Institutes of Health Clinical Center (CC) ranks in the top decile of sponsors by registered trial count (#107 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
272 of 308 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.3%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
338 total, page 4 of 7
Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease
NCT00393250
Effects of Antibodies to White Blood Cells on Platelet Transfusion Patients
NCT00460122
Lenalidomide, Sunitinib, and Cyclophosphamide in Treating Patients With Stage IV Eye Melanoma
NCT00482911
Molecular Changes and Biomarkers in Chronic Myeloproliferative Disorders
NCT00433862
Research Participants' Views on the Ethics of Clinical Research
NCT00457041
Education Program to Manage Emotional Stress of Stem Cell Transplant Recipients and Their Caregivers
NCT00423774
Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
NCT00436410
Development of Serologic Assays for Human Herpes Virus-8
NCT00395278
Decision-Making of Hispanics and African-Americans With HIV/AIDS Participating in Clinical Trials
NCT00394004
Effectiveness of Short-Course Versus Standard Antibiotic Therapy in ICU Patients
NCT00410527
Vaccine Therapy, Incomplete Freund's Adjuvant, and GM-CSF in Treating Patients With HIV
NCT00381875
Transplant-Related Accelerated Progression of Hepatitis C
NCT00368225
ABT-888 in Patients With Refractory Solid Tumors or Hematologic Cancer
NCT00387608
Iron Replacement in Blood Donors
NCT00327067
Cardiomyopathy Following Stem Cell Transplantation
NCT00352209
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis
NCT00132015
TNF-Bound Colloidal Gold in Treating Patients With Advanced Solid Tumors
NCT00356980
ATN-161 and Carboplatin in Treating Patients With Recurrent Malignant Glioma
NCT00352313
Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial
NCT00316901
Three Different Types of Thermometers in Measuring Temperature in Young Patients With Fever and Without Fever
NCT00378846
OT-551 Antioxidant Eye Drops to Treat Geographic Atrophy in Age-Related Macular Degeneration
NCT00306488
LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery
NCT00295958
Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
NCT00303940
Trastuzumab and Pertuzumab in Treating Patients With Unresectable Locally Advanced or Metastatic Breast Cancer That Did Not Respond to Previous Trastuzumab
NCT00301899
Effect of Genetics on Metabolism of Efavirenz
NCT00245986
Developing Interview Questions to Estimate Workplace Exposure to Electric and Magnetic Fields
NCT00340054
Evaluation of Brain Lesions in HIV-infected Patients for Diagnosis of Primary Central Nervous System Lymphoma
NCT00226304
PEG-Interferon Alfa-2b in Treating Young Patients With Plexiform Neurofibroma
NCT00253474
Quality of Life in Patients Who Have Undergone Stem Cell Transplant
NCT00128960
Pharmacokinetics of Mycophenolate Mofetil in Healthy Volunteers
NCT00128947
Cyclophosphamide and Fludarabine Followed By an Autologous Lymphocyte Infusion and Interleukin-2 in Treating Patients With Refractory or Recurrent Metastatic Melanoma
NCT00138229
Gait Adaptations to Passive Dynamic Ankle-Foot Orthosis Use
NCT00115401
Heart Disease in Sickle Cell Anemia
NCT00113152
Acamprosate to Reduce Symptoms of Alcohol Withdrawal
NCT00106106
Effects of Pet Therapy on Pain in Cancer Patients
NCT00431639
Sensing of Leg Position and Movement
NCT00100919
Drug Interactions of Echinacea, Ginseng, and Ginkgo Biloba Taken With Lopinavir/Ritonavir in Healthy Volunteers
NCT00103012
Evaluation of Patients With Critical Illness
NCT00100217
Views of Cancer Patients Regarding Financial Conflicts of Interest
NCT00097682
Impact of Move to Clinical Research Center on Physical Activity of Employees
NCT00095485
Carbon Monoxide to Prevent Lung Inflammation
NCT00094406
The Effect of Sildenafil Citrate (Viagra® (Registered Trademark)) on Brain Blood Flow in Multiple Sclerosis Patients
NCT00094068
Revising Employee Benefits for the Sake of Health
NCT00097461
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
NCT00093444
Paclitaxel and ABI-007 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
NCT00095914
Cyclophosphamide, Fludarabine, and Total-Body Irradiation Followed By Cellular Adoptive Immunotherapy, Autologous Stem Cell Transplantation, and Interleukin-2 in Treating Patients With Metastatic Melanoma
NCT00096382
Cyclophosphamide and Fludarabine Followed by Vaccine Therapy, Gene-Modified White Blood Cell Infusions, and Aldesleukin in Treating Patients With Metastatic Melanoma
NCT00091104
Effect of Respiratory Motion on Positron Emission Tomography Imaging
NCT00088361
Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver
NCT00089401
17-Dimethylaminoethylamino-17-demethoxygeldanamycin (17-DMAG) in Treating Patients With an Advanced Solid Tumor or Lymphoma
NCT00088868
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 74 |
| Phase 2 | 47 |
| Phase 3 | 6 |
| Phase 4 | 11 |
Therapeutic Areas
What is open in the National Institutes of Health Clinical Center (CC) pipeline
22 recruiting of 338 indexed (7% open); 272 completed (80%).
Phase mix: 17 late (III/IV) vs 121 early (I/II) (early-phase heavy).
Top condition: Healthy (8 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
National Institutes of Health Clinical Center (CC): open-pipeline peers nationwide
Peers matched on 338 registered trials and 7% open enrollment, not the therapeutic-area sidebar.
National Institutes of Health Clinical Center (CC) sits at or above the median trial volume and below the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 338 trials (± recruiting share)
- Cedars-Sinai Medical Center · 339 trials · 21% recruiting
- Ohio State University Comprehensive Cancer Center · 341 trials · 23% recruiting
- National Institute on Drug Abuse (NIDA) · 335 trials · 4% recruiting
- Children's Oncology Group · 342 trials · 10% recruiting
Sponsors near 7% open enrollment (± trial volume)
- Alliance for Clinical Trials in Oncology · 7% recruiting · 446 trials
- NICHD Neonatal Research Network · 7% recruiting · 61 trials
- Insmed Incorporated · 6% recruiting · 31 trials
- Baylor Breast Care Center · 7% recruiting · 15 trials
Related
What to do with this National Institutes of Health Clinical Center (CC) page
338 registered trials is a research-attention snapshot, not an endorsement of National Institutes of Health Clinical Center (CC) or any single study.
- 22 of National Institutes of Health Clinical Center (CC)'s trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Healthy is the condition National Institutes of Health Clinical Center (CC) studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Healthy trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
National Institutes of Health Clinical Center (CC) pipeline card: 338 registered trials from official public datasets.Report a data error.